These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28595037)

  • 21. Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.
    García-Fernández A; Lain JM; Chabrera C; García Font M; Fraile M; Barco I; Torras M; Reñe A; González S; González C; Piqueras M; Veloso E; Cirera L; Pessarrodona A; Giménez N
    Breast J; 2015; 21(5):533-7. PubMed ID: 26190560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metaplastic breast cancer: a comparison between the most common histologies with poor immunohistochemistry factors.
    Barquet-Muñoz SA; Villarreal-Colin SP; Herrera-Montalvo LA; Soto-Reyes E; Pérez-Plasencia C; Coronel-Martínez J; Pérez-Montiel D; Vázquez-Romo R; Cantú de León D
    BMC Cancer; 2015 Feb; 15():75. PubMed ID: 25881163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA ploidy is an independent predictor of survival in breast invasive ductal carcinoma: a long-term multivariate analysis of 393 patients.
    Pinto AE; Pereira T; Santos M; Branco M; Dias A; Silva GL; Ferreira MC; André S
    Ann Surg Oncol; 2013 May; 20(5):1530-7. PubMed ID: 23250736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent effects of insulin-like growth factor-1 receptor expression on prognosis of estrogen receptor positive versus triple negative invasive ductal breast carcinoma.
    Hartog H; Horlings HM; van der Vegt B; Kreike B; Ajouaou A; van de Vijver MJ; Marike Boezen H; de Bock GH; van der Graaf WT; Wesseling J
    Breast Cancer Res Treat; 2011 Oct; 129(3):725-36. PubMed ID: 21107683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes.
    Cristofanilli M; Gonzalez-Angulo A; Sneige N; Kau SW; Broglio K; Theriault RL; Valero V; Buzdar AU; Kuerer H; Buchholz TA; Hortobagyi GN
    J Clin Oncol; 2005 Jan; 23(1):41-8. PubMed ID: 15625359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased serum apolipoprotein A1 level predicts poor prognosis of patients with de novo myelodysplastic syndromes.
    Shi C; Gong S; Wu A; Yang S; Zou D; Zhang Y; Wu N; Ma C; Shi S; Chen Y; Wu Y; Zheng X; Huang Z; Ding J; Ouyang G; Mu Q
    BMC Cancer; 2022 Jan; 22(1):127. PubMed ID: 35100989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study.
    Hsu MC; Lee KT; Hsiao WC; Wu CH; Sun HY; Lin IL; Young KC
    BMC Cancer; 2013 Jul; 13():330. PubMed ID: 23829168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Pretreatment Serum Apolipoprotein A1 and Prognosis of Solid Tumors in Chinese Population: A Systematic Review and Meta-Analysis.
    Wu J; Zhang C; Zhang G; Wang Y; Zhang Z; Su W; Lyu J
    Cell Physiol Biochem; 2018; 51(2):575-588. PubMed ID: 30466099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological Features and Prognosis of Metaplastic Breast Carcinoma: Experience of a Major Chinese Cancer Center.
    Zhang Y; Lv F; Yang Y; Qian X; Lang R; Fan Y; Liu F; Li Y; Li S; Shen B; Pringle GA; Zhang X; Fu L; Guo X
    PLoS One; 2015; 10(6):e0131409. PubMed ID: 26115045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
    Chen HL; Ding A
    Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association with pregnancy increases the risk of local recurrence but does not impact overall survival in breast cancer: A case-control study of 87 cases.
    Genin AS; De Rycke Y; Stevens D; Donnadieu A; Langer A; Rouzier R; Lerebours F
    Breast; 2016 Dec; 30():222-227. PubMed ID: 26456897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in Prognostic Factors and Failure Patterns Between Invasive Micropapillary Carcinoma and Carcinoma With Micropapillary Component Versus Invasive Ductal Carcinoma of the Breast: Retrospective Multicenter Case-Control Study (KROG 13-06).
    Yu JI; Choi DH; Huh SJ; Cho EY; Kim K; Chie EK; Ha SW; Park IA; Ahn SJ; Lee JS; Shin KH; Kwon Y; Kim YB; Suh CO; Koo JS; Kim JH; Jeong BG; Kim IA; Lee JH; Park W
    Clin Breast Cancer; 2015 Oct; 15(5):353-61.e1-2. PubMed ID: 25776197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
    Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
    BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ratio between positive lymph nodes and total excised axillary lymph nodes as an independent prognostic factor for overall survival in patients with nonmetastatic lymph node-positive breast cancer.
    Hatoum HA; Jamali FR; El-Saghir NS; Musallam KM; Seoud M; Dimassi H; Abbas J; Khalife M; Boulos FI; Tawil AN; Geara FB; Salem Z; Shamseddine AA; Al-Feghali K; Shamseddine AI
    Ann Surg Oncol; 2009 Dec; 16(12):3388-95. PubMed ID: 19655200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?
    Jayasinghe UW; Bilous AM; Boyages J
    Breast J; 2007; 13(5):479-85. PubMed ID: 17760669
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathological significance of CD133 and CD44 expression in infiltrating ductal carcinoma and their relationship to angiogenesis.
    Han Z; Chen Z; Zheng R; Cheng Z; Gong X; Wang D
    World J Surg Oncol; 2015 Feb; 13():56. PubMed ID: 25889325
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of failure patterns between tubular breast carcinoma and invasive ductal carcinoma (KROG 14-25).
    Cho WK; Choi DH; Lee J; Park W; Kim YB; Suh CO; Shin KH; Jeon SH; Kim K; Park KR; Kim JH; Ahn SJ; Yoon WS; Yang DS; Kim J; Lee JH; Yea JW
    Breast; 2018 Apr; 38():165-170. PubMed ID: 29413404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic implication of the tumor location according to molecular subtypes in axillary lymph node-positive invasive ductal cancer in a Korean population.
    Lim ST; Choi JE; Kim SJ; Kim HA; Kim JY; Park HK; Suh YJ
    Breast Cancer Res Treat; 2016 Apr; 156(3):473-483. PubMed ID: 27041335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
    Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
    Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.